Compare DLHC & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLHC | LFVN |
|---|---|---|
| Founded | 1969 | N/A |
| Country | United States | United States |
| Employees | 2300 | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.4M | 78.0M |
| IPO Year | 2012 | 1996 |
| Metric | DLHC | LFVN |
|---|---|---|
| Price | $5.09 | $6.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 30.6K | ★ 215.3K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | N/A | ★ 226.09 |
| EPS | N/A | ★ 0.30 |
| Revenue | $41,923,000.00 | ★ $203,204,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.05 | N/A |
| P/E Ratio | ★ N/A | $20.90 |
| Revenue Growth | ★ 2.57 | 1.86 |
| 52 Week Low | $5.03 | $3.90 |
| 52 Week High | $8.09 | $15.00 |
| Indicator | DLHC | LFVN |
|---|---|---|
| Relative Strength Index (RSI) | 40.99 | 46.35 |
| Support Level | $5.08 | $5.93 |
| Resistance Level | $5.66 | $6.41 |
| Average True Range (ATR) | 0.17 | 0.23 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 11.29 | 77.78 |
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.